EMEA (Middle East & Africa)
HanchorBio Licenses Novel CD47 Fusion Protein HCB101 to Henlius in $200 Million+ Regional Deal
HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, annou...
July 02, 2025 | News
Porton Advanced and EVA Pharma Partner to Boost CAR T-Cell Therapy Manufacturing in the Middle East and Africa
Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies d...
June 27, 2025 | News
EVA Pharma and CHICO Pharmaceutical Join Forces to Localize Oncology API Production for Middle East and Africa
On the sidelines of CPHI China 2025, EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle Eas...
June 25, 2025 | News
Koning Health Debuts in UAE with Instalalation of Region’s First No-Compression 3D Breast Imaging System
Koning Health is proud to announce the installation of the Koning Vera at the Family Health Promotion Center in Sharjah, United Arab Emirat...
June 24, 2025 | News
Abu Dhabi and Sanofi Sign Strategic MoU to Drive Global Vaccine Innovation and Manufacturing from the UAE
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of...
June 20, 2025 | News
MedHub-AI Secures PMDA Approval in Japan for AutocathFFR®, the World’s First Fully Automated AI-Driven FFR Solution
MedHub-AI, a global leader in AI-powered cardiovascular diagnostics, announced today that the Pharmaceuticals and Medical Devices Agency (PMDA) in&nb...
June 19, 2025 | News
BioDlink Secures NAFDAC Approval for Bevacizumab Injection, Marking Strategic Entry into the African Market
BioDlink's Bevacizumab Injection has been granted marketing authorization by Nigeria's National Agency for Food and Drug Administration an...
June 17, 2025 | News
Teva and Fosun Pharma Enter Strategic Partnership to Advance Anti-PD1-IL2 ATTENUKINE™ Therapy TEV-56278 for Oncology
Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun...
June 17, 2025 | News
Abu Dhabi Department of Health and Boehringer Ingelheim Forge Strategic Partnership to Advance Life Sciences and Innovation at BIO 2025
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU)...
June 17, 2025 | News
ASP Isotopes and Isotopia Forge Strategic Alliance to Secure Gd-160 Supply for Next-Gen Cancer Radiotherapeutics
ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160...
June 02, 2025 | News
KFSHRC and Cellenkos Join Forces to Launch First Saudi-U.S. Clinical Trials for Treg Cell Therapies
KFSHRC to lead Clinical Trials Targeting Aplastic Anemia and Graft vs. Host Disease Cellenkos to Support Local Cell and Gene Therapy Manufacturing at&nb...
May 23, 2025 | News
IASO Bio’s BCMA CAR-T Therapy Equecabtagene Autoleucel Granted Orphan Drug Designation in Saudi Arabia
IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovat...
May 12, 2025 | News
Colorcon Enters Exclusive Partnership with ASHA Cellulose to Expand Ethyl Cellulose Offerings Across Asia, EMEA
Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled atmosphere packaging for the health...
May 09, 2025 | News
Abu Dhabi Leads Global Call for AI Governance in Healthcare at ADGHW Roundtable
Held during Abu Dhabi Global Health Week, the roundtable united global health leaders to shape a Declaration on AI governance principles for healthcare ...
April 25, 2025 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
